It has been found that[34] ASPM is widely expressed in lung squamous cell carcinoma and co-expressed with CDK4, a cytokine-dependent kinase 4, which has been identified as a potential target against COVID-19, and it has been shown that inhibition of CDK4 activity prevents viral replication and allows systemic inflammatory symptoms to be alleviated. This evidence concerns the gene ASPM and COVID-19.